MedPath

Sodium Diuril

IntravenousSodium Diuril (chlorothiazide sodium)

Approved
Approval ID

1d9fa4e6-6516-45cd-a316-292c6a529ecc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 1, 2022

Manufacturers
FDA

Akorn

DUNS: 117693100

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

chlorothiazide sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76478-711
Application NumberNDA011145
Product Classification
M
Marketing Category
C73594
G
Generic Name
chlorothiazide sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 12, 2012
FDA Product Classification

INGREDIENTS (3)

mannitolInactive
Code: 3OWL53L36A
Classification: IACT
chlorothiazide sodiumActive
Quantity: 0.5 mg in 18 mL
Code: SN86FG7N2K
Classification: ACTIM
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Diuril - FDA Drug Approval Details